6/7/2025

Janusmed sex and gender

Janusmed sex and gender – Ruxolitinib – topical

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Ruxolitinib – topical

Ruxolitinib – topical

Class : B

Show all info

Print

Contact us

  1. Gong X, Chen X, Kuligowski ME, Liu X, Liu X, Cimino E et al. Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies. Am J Clin Dermatol. 2021;22(4):555-566.

  2. Opzelura (ruxolitinib phosphate). Incyte Biosciences Distribution B.V. EMA EPAR Product Information. Published 20/04/2023

  3. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2023 [cited 2024-03-06.]

  1. Gong X, Chen X, Kuligowski ME, Liu X, Liu X, Cimino E et al. Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies. Am J Clin Dermatol. 2021;22(4):555-566.
  2. Opzelura (ruxolitinib phosphate). Incyte Biosciences Distribution B.V. EMA EPAR Product Information. Published 20/04/2023
  3. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2023 [cited 2024-03-06.]